My NCBISign In
Predicting progression of Alzheimer's disease
Rachelle S Doody, Valory Pavlik, Paul Massman, Susan Rountree, Eveleen Darby, Wenyaw Chan
Alzheimers Res Ther. 2010; 2(1): 2. Published online 2010 February 23. doi: 10.1186/alzrt25
Correction in:
Alzheimers Res Ther. 2010; 2(3): 14.
PMCID:
PMC2874261
Abstract Full Text PDF–253K Correction

Is Cited by the Following 9 Articles in this Archive:

Calculating Stage Duration Statistics in Multistage Diseases
Natalia L. Komarova, Craig J. Thalhauser
PLoS One. 2011; 6(12): e28298. Published online 2011 December 7. doi: 10.1371/journal.pone.0028298
PMCID:
PMC3233570
Abstract Full Text PDF–503K Supplementary Material
High Degree of Heterogeneity in Alzheimer's Disease Progression Patterns
Natalia L. Komarova, Craig J. Thalhauser
PLoS Comput Biol. 2011 November; 7(11): e1002251. Published online 2011 November 3. doi: 10.1371/journal.pcbi.1002251
PMCID:
PMC3207941
Abstract Full Text PDF–269K Supplementary Material
Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment
Valory N Pavlik, Rachelle S Doody
Alzheimers Res Ther. 2011; 3(5): 30. Published online 2011 October 17. doi: 10.1186/alzrt92
PMCID:
PMC3218807
Abstract Full Text PDF–136K
Galantamine treatment in Alzheimer’s disease: response and long-term outcome in a routine clinical setting
Åsa K Wallin, Carina Wattmo, Lennart Minthon
Neuropsychiatr Dis Treat. 2011; 7: 565–576. Published online 2011 September 30. doi: 10.2147/NDT.S24196
PMCID:
PMC3191869
Abstract Full Text PDF–273K
Predictors of long-term cognitive outcome in Alzheimer's disease
Carina Wattmo, Åsa K Wallin, Elisabet Londos, Lennart Minthon
Alzheimers Res Ther. 2011; 3(4): 23. Published online 2011 July 20. doi: 10.1186/alzrt85
PMCID:
PMC3226278
Abstract Full Text PDF–2.9M
Test-Retest Reliability of Memory Task fMRI in Alzheimer’s Disease Clinical Trials
Dr. Alireza Atri, Dr. Jacqueline L. O’Brien, Dr. Aishwarya Sreenivasan, Dr. Sarah Rastegar, Dr. Sibyl Salisbury, Dr. Amy N. DeLuca, Dr. Kelly M. O’Keefe, Dr. Peter S. LaViolette, Dr. Dorene M. Rentz, Dr. Joseph J. Locascio, Dr. Reisa A. Sperling
Arch Neurol. Author manuscript; available in PMC 2012 March 1.
Published in final edited form as: Arch Neurol. 2011 May; 68(5): 599–606. doi: 10.1001/archneurol.2011.94
PMCID:
PMC3291175
Abstract Full Text PDF–684K Supplementary Material
For debate: substituting placebo controls in long-term Alzheimer's prevention trials
René Spiegel, Manfred Berres, André R Miserez, Andreas U Monsch
Alzheimers Res Ther. 2011; 3(2): 9. Published online 2011 March 21. doi: 10.1186/alzrt68
PMCID:
PMC3226271
Abstract Full Text PDF–401K
Plasma sphingomyelins are associated with cognitive progression in Alzheimer’s Disease
Michelle M. Mielke, Norman J. Haughey, Veera Venkata Ratnam Bandaru, Danielle D. Weinberg, Eveleen Darby, Noman Zaidi, Valory Pavlik, Rachelle S. Doody, Constantine G. Lyketsos
J Alzheimers Dis. Author manuscript; available in PMC 2011 November 17.
Published in final edited form as: J Alzheimers Dis. 2011 January 1; 27(2): 259–269. doi: 10.3233/JAD-2011-110405
PMCID:
PMC3218198
Abstract Full Text PDF–675K
Correction: Predicting progression of Alzheimer's disease
Rachelle S Doody, Valory Pavlik, Paul Massman, Susan Rountree, Eveleen Darby, Wenyaw Chan
Alzheimers Res Ther. 2010; 2(3): 14. Published online 2010 May 18. doi: 10.1186/alzrt38
Corrects:
Alzheimers Res Ther. 2010; 2(1): 2.
PMCID:
PMC2919694
Correction PDF–150K Original Article
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk